Leveraging years of R&D expertise and extensive project experience, KMD Bioscience's antibody development platform has established mature capabilities in generating phosphorylation-specific antibodies. The phosphorylation-specific polyclonal and monoclonal antibodies we develop demonstrate performance comparable to that of comparable products from Cell Signaling Technology (CST). We offer clients a one-stop, end-to-end service for phosphorylation antibody preparation, covering phosphorylated peptide antigen design, customized experimental protocol planning, and multi-dimensional antibody validation. Our validation system includes cross‑reactivity testing against phosphorylated versus non‑phosphorylated antigens, as well as application assessments in Western blotting and immunohistochemistry, thereby fully addressing the diverse project requirements of different clients.
Protein phosphorylation is a core class of post‑translational modifications (PTMs) within cells. By mediating the activation or inhibition of target protein biological activities, it precisely regulates the operation of intracellular signal transduction pathways and represents a critical molecular mechanism governing cellular functions. In eukaryotes, protein phosphorylation predominantly occurs on serine, threonine, and tyrosine residues; histidine phosphorylation, in contrast, is the most representative form of phosphorylation regulation in prokaryotes. Leveraging our well-established phage display technology platform, KMD Bioscience further provides customized preparation services for phosphorylation‑specific recombinant monoclonal antibodies to meet specialized project needs.
0
